Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

What are the implications of a VP shunt located in the radiation field in a patient receiving treatment for breast cancer?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I don’t see any contradiction to RT here.

What is the appropriate dose to the dissected node-negative neck with indication for radiation due to advanced primary?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

60 Gy/30 fractions if HPV negative. 50 Gy/25 fractions or equivalent if HPV-positive OPX.

What is your approach to nodal coverage in a patient with lateralized adenoid cystic carcinoma (ie., buccal mucosa) with positive lymph node(s)?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Medical University of South Carolina (Charleston)

I would cover the ipsilateral neck and named nerve to at least the foramina at the skull base.

Will you wait to simulate, or resimulate, a patient after teeth extractions in preparation for HN cancer treatment?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

The answer is, it depends. I do not have a specific policy, and it depends refers to which and how many teeth need to be extracted. The main questions to answer this question are: Will the extractions alter the set up? And as a corollary, will the extractions alter the use of an intraoral device? A...

How would you manage an elderly patient with a de novo TNBC in the setting of a remote prior ipsilateral breast cancer s/p mastectomy and implant?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Unusual case: Looks like a new primary based on the timeline and presuming repeat SNLN was done and is negative. If local treatment is adequate as above, one can skip RT. Otherwise, I would favor RT. Also, obtain BRCA testing.

Should the hemorrhage be included in the volume when treating brain mets with SRS?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Kaiser Permanente

Having seen hemorrhage around brain metastases which later resolves, revealing uninvolved parenchyma, I do not include extralesional hemorrhage in the target volume when treating brain metastases with SRS. In patients for whom the edges of metastases are obfuscated by blood, I tend to favor whole br...

Do you recommend adjuvant radiotherapy for an adult patient with localized myxopapillary ependymoma, WHO Grade 2, status-post gross total resection?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

I assumed that this is a case of spinal ependymoma. Myxopapillary ependymomas are rare tumors and optimal therapeutic strategy involves a Gross Total Resection (GTR). The more complete the surgery the better the outcome. The role of postoperative radiation after a GTR is somewhat controversial but I...

Do you recommend neoadjuvant 177Lu-PNT2002 followed by MDT per the LUNAR trial as your preferred treatment approach for oligorecurrent prostate cancer, as opposed to MDT and PSMA-radioligand therapy used as temporally separate treatments?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · David Geffen School of Medicine at UCLA

I believe this randomized trial does provide high-level evidence that adding 177Lu-PNT2002 prior to SBRT improves PFS compared with SBRT alone. If it were available off trial, yes, I would personally recommend it as an option. Currently, that is not the case.We chose this sequencing because we thoug...

What SBRT dose would you give to a single external iliac lymph node recurrence (1 cm size) for a patient previously treated with salvage radiation to the pelvis?

1
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Sunnybrook Health Sciences Centre

35 Gy/5 is fairly safe in the re-irradiation setting, and in our experience, it's quite effective for nodal disease.

How do you manage the elective lymphatics in high risk squamous cell carcinoma of the skin?

7
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · UTMB

For the high risk features mentioned in the question, elective RT to draining nodes and neural pathways should be considered. The acceptable dose/fx for elective RT in SCC is generally 50 Gy in 25 fx (ranges from 45-54 Gy). <1.8-2 Gy/fx is acceptable in dose painted plans. For the nodal fields a goo...